Deciphera Pharmaceuticals Inc (DCPH)
25.47
+0.01
(+0.04%)
USD |
NASDAQ |
May 20, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Total Liabilities (Quarterly): 104.88M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 104.88M |
December 31, 2023 | 122.65M |
September 30, 2023 | 116.17M |
June 30, 2023 | 105.19M |
March 31, 2023 | 108.94M |
December 31, 2022 | 112.35M |
September 30, 2022 | 102.18M |
June 30, 2022 | 102.03M |
March 31, 2022 | 113.90M |
December 31, 2021 | 124.76M |
September 30, 2021 | 102.96M |
June 30, 2021 | 93.91M |
March 31, 2021 | 92.23M |
December 31, 2020 | 98.76M |
September 30, 2020 | 90.58M |
Date | Value |
---|---|
June 30, 2020 | 66.62M |
March 31, 2020 | 60.67M |
December 31, 2019 | 75.94M |
September 30, 2019 | 44.05M |
June 30, 2019 | 37.13M |
March 31, 2019 | 29.69M |
December 31, 2018 | 35.58M |
September 30, 2018 | 36.55M |
June 30, 2018 | 37.06M |
March 31, 2018 | 17.55M |
December 31, 2017 | 15.12M |
September 30, 2017 | 255.98M |
June 30, 2017 | 9.606M |
December 31, 2016 | 198.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
37.13M
Minimum
Jun 2019
124.76M
Maximum
Dec 2021
93.79M
Average
102.10M
Median
Total Liabilities (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 82.48B |
Dynavax Technologies Corp | 368.08M |
Gilead Sciences Inc | 38.84B |
Esperion Therapeutics Inc | 667.36M |
SINTX Technologies Inc | 7.635M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 420.93M |
Shareholders Equity (Quarterly) | 316.05M |
Current Ratio | 4.194 |